Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Emphysema phenotypes and lung cancer risk.

González J, Henschke CI, Yankelevitz DF, Seijo LM, Reeves AP, Yip R, Xie Y, Chung M, Sánchez-Salcedo P, Alcaide AB, Campo A, Bertó J, Del Mar Ocón M, Pueyo J, Bastarrika G, de-Torres JP, Zulueta JJ.

PLoS One. 2019 Jul 25;14(7):e0219187. doi: 10.1371/journal.pone.0219187. eCollection 2019.

2.

Programmed death-ligand 1 expression on direct Pap-stained cytology smears from non-small cell lung cancer: Comparison with cell blocks and surgical resection specimens.

Lozano MD, Abengozar-Muela M, Echeveste JI, Subtil JC, Bertó J, Gúrpide A, Calvo A, de Andrea CE.

Cancer Cytopathol. 2019 Jul;127(7):470-480. doi: 10.1002/cncy.22155. Epub 2019 Jun 27.

PMID:
31245924
3.

Trabecular bone score in active or former smokers with and without COPD.

González J, Rodríguez-Fraile M, Rivera P, Restituto P, Colina I, Calleja MLD, Alcaide AB, Campo A, Bertó J, Seijo LM, Pérez T, Zulueta J, Varo N, de-Torres JP.

PLoS One. 2019 Feb 1;14(2):e0209777. doi: 10.1371/journal.pone.0209777. eCollection 2019.

4.

Pulmonary arterial enlargement predicts long-term survival in COPD patients.

de-Torres JP, Ezponda A, Alcaide AB, Campo A, Berto J, Gonzalez J, Zulueta JJ, Casanova C, Rodriguez-Delgado LE, Celli BR, Bastarrika G.

PLoS One. 2018 Apr 25;13(4):e0195640. doi: 10.1371/journal.pone.0195640. eCollection 2018.

5.

Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort.

Divo MJ, Celli BR, Poblador-Plou B, Calderón-Larrañaga A, de-Torres JP, Gimeno-Feliu LA, Bertó J, Zulueta JJ, Casanova C, Pinto-Plata VM, Cabrera-Lopez C, Polverino F, Carmona Píréz J, Prados-Torres A, Marin JM; EpiChron—BODE Collaborative Group.

PLoS One. 2018 Feb 22;13(2):e0193143. doi: 10.1371/journal.pone.0193143. eCollection 2018.

6.

Telomere length, COPD and emphysema as risk factors for lung cancer.

de-Torres JP, Sanchez-Salcedo P, Bastarrika G, Alcaide AB, Pío R, Pajares MJ, Campo A, Berto J, Montuenga L, Del Mar Ocon M, Monente C, Celli BR, Zulueta JJ.

Eur Respir J. 2017 Jan 3;49(1). pii: 1601521. doi: 10.1183/13993003.01521-2016. Print 2017 Jan. No abstract available.

7.

Prolonged use of tedizolid in a pulmonary non-tuberculous mycobacterial infection after linezolid-induced toxicity.

Yuste JR, Bertó J, Del Pozo JL, Leiva J.

J Antimicrob Chemother. 2017 Feb;72(2):625-628. doi: 10.1093/jac/dkw484. Epub 2016 Dec 20. No abstract available.

PMID:
27999019
8.

Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation.

Alcaide AB, Sanchez-Salcedo P, Bastarrika G, Campo A, Berto J, Ocon MD, Fernandez-Montero A, Celli BR, Zulueta JJ, de-Torres JP.

Chest. 2017 Feb;151(2):358-365. doi: 10.1016/j.chest.2016.10.044. Epub 2016 Nov 3.

PMID:
27818328
9.

Integrating climate-smart rice agriculture into secondary-level curriculum: lessons from three high schools in the Philippines.

Manalo JA 4th, Balmeo KP, Berto JC, Saludez FM, Villaflor JD, Pagdanganan AM.

Springerplus. 2016 Sep 17;5(1):1592. doi: 10.1186/s40064-016-3238-6. eCollection 2016.

10.

[Lung cancer screening using low-dose computed tomography. In favour].

Bertó J, Zulueta JJ.

Gac Sanit. 2016 Sep-Oct;30(5):386-8. doi: 10.1016/j.gaceta.2016.07.001. Epub 2016 Jul 25. Spanish. No abstract available.

11.

The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development.

Sanchez-Salcedo P, de-Torres JP, Martinez-Urbistondo D, Gonzalez-Gutierrez J, Berto J, Campo A, Alcaide AB, Zulueta JJ.

Lung Cancer. 2016 Jul;97:28-34. doi: 10.1016/j.lungcan.2016.04.010. Epub 2016 Apr 16.

PMID:
27237024
12.

Is COPD a Progressive Disease? A Long Term Bode Cohort Observation.

de-Torres JP, Marín JM, Pinto-Plata V, Divo M, Sanchez-Salcedo P, Zagaceta J, Zulueta JJ, Berto J, Cabrera C, Celli BR, Casanova C.

PLoS One. 2016 Apr 21;11(4):e0151856. doi: 10.1371/journal.pone.0151856. eCollection 2016.

13.

COPD comorbidities network.

Divo MJ, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta JJ, Cabrera C, Zagaceta J, Sanchez-Salcedo P, Berto J, Davila RB, Alcaide AB, Cote C, Celli BR; BODE Collaborative Group.

Eur Respir J. 2015 Sep;46(3):640-50. doi: 10.1183/09031936.00171614. Epub 2015 Jul 9.

14.

Improving selection criteria for lung cancer screening. The potential role of emphysema.

Sanchez-Salcedo P, Wilson DO, de-Torres JP, Weissfeld JL, Berto J, Campo A, Alcaide AB, Pueyo J, Bastarrika G, Seijo LM, Pajares MJ, Pio R, Montuenga LM, Zulueta JJ.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):924-31. doi: 10.1164/rccm.201410-1848OC.

15.

Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).

Sanchez-Salcedo P, Berto J, de-Torres JP, Campo A, Alcaide AB, Bastarrika G, Pueyo JC, Villanueva A, Echeveste JI, Lozano MD, García-Velloso MJ, Seijo LM, García J, Torre W, Pajares MJ, Pío R, Montuenga LM, Zulueta JJ.

Arch Bronconeumol. 2015 Apr;51(4):169-76. doi: 10.1016/j.arbres.2014.09.019. Epub 2015 Jan 29. English, Spanish.

16.

Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.

de-Torres JP, Wilson DO, Sanchez-Salcedo P, Weissfeld JL, Berto J, Campo A, Alcaide AB, García-Granero M, Celli BR, Zulueta JJ.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):285-91. doi: 10.1164/rccm.201407-1210OC.

17.

Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index.

Divo MJ, Cabrera C, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta J, Zagaceta J, Sanchez-Salcedo P, Berto J, Cote C, Celli BR.

Chronic Obstr Pulm Dis. 2014 Sep 25;1(2):229-238. doi: 10.15326/jcopdf.1.2.2014.0117.

18.

Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.

de Torres JP, Casanova C, Marín JM, Pinto-Plata V, Divo M, Zulueta JJ, Berto J, Zagaceta J, Sanchez-Salcedo P, Cabrera C, Carrizo S, Cote C, Celli BR.

Thorax. 2014 Sep;69(9):799-804. doi: 10.1136/thoraxjnl-2014-205770. Epub 2014 Jun 26.

PMID:
24969641
19.

Physico-chemical, microbiological and ecotoxicological evaluation of a septic tank/Fenton reaction combination for the treatment of hospital wastewaters.

Berto J, Rochenbach GC, Barreiros MA, Corrêa AX, Peluso-Silva S, Radetski CM.

Ecotoxicol Environ Saf. 2009 May;72(4):1076-81. doi: 10.1016/j.ecoenv.2008.12.002. Epub 2009 Jan 23.

PMID:
19167756
20.

A simple methodology to evaluate influence of H2O2 and Fe(2+) concentrations on the mineralization and biodegradability of organic compounds in water and soil contaminated with crude petroleum.

Mater L, Rosa EV, Berto J, Corrêa AX, Schwingel PR, Radetski CM.

J Hazard Mater. 2007 Oct 22;149(2):379-86. Epub 2007 Apr 5.

PMID:
17493749
21.

[Merkel cell carcinoma. Study of five cases].

Bertó J, Cuenca A, Díaz-Martínez B, Peña ML, Ruiz-Fernández P, Sánchez de Paz F.

Actas Dermosifiliogr. 2005 Mar;96(2):106-10. Spanish.

PMID:
16476346
22.

Occupational allergic contact dermatitis from antioxidant amines in a dental technician.

Conde-Salazar L, Valks R, Acebes CG, Bertó J.

Dermatitis. 2004 Dec;15(4):197-200.

PMID:
15842064
23.

Increased incidence of pneumococcal bloodstream infections.

Rodríguez-Créixems M, Bertó J, Muñoz P, Alonso R, Alcalá L, Bouza E.

Pediatr Infect Dis J. 2003 Jul;22(7):661-3.

PMID:
12886897
24.
25.

Siberian hamster: a new indoor source of allergic sensitization and respiratory disease.

Bertó JM, Peláez A, Fernández E, Lombardero M, Ferrer M.

Allergy. 2002 Feb;57(2):155-9.

PMID:
11929420
26.

Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.

Gutiérrez V, Prieto L, Torres V, Trenor R, Pérez C, Bertó JM, Marín J.

Ann Allergy Asthma Immunol. 1999 Jun;82(6):559-65.

PMID:
10400484
27.

Sensitivity and maximal response to methacholine in perennial and seasonal allergic rhinitis.

Prieto JL, Gutiérrez V, Bertó JM, Camps B.

Clin Exp Allergy. 1996 Jan;26(1):61-7.

PMID:
8789544
28.

Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis.

Prieto L, Gutiérrez V, Bertó JM, Tornero C, Camps B, Pérez MJ.

Ann Allergy Asthma Immunol. 1995 Sep;75(3):273-9.

PMID:
7552931
29.

[Relations between nonspecific bronchial hyperreactivity, diurnal variation of peak expiratory flow and medication requirements in patients with mild asthma].

Prieto L, Gutiérrez V, Bertó JM, Camps B, Pérez MJ.

Arch Bronconeumol. 1994 Nov;30(9):433-9. Spanish.

PMID:
8000691
30.
32.

Airway responsiveness to methacholine and risk of asthma in patients with allergic rhinitis.

Prieto L, Bertó JM, Gutierrez V.

Ann Allergy. 1994 Jun;72(6):534-9.

PMID:
8203797
33.
34.

Lung function and bronchial response to methacholine in young adults who had asthma in childhood.

Bertó JM, López C, Pino JM, Ojeda JA, Marin J.

Ann Allergy. 1993 Jan;70(1):40-3.

PMID:
8424595

Supplemental Content

Support Center